Impact Proteomics strives to see what the immune system sees with our advanced immune-profiling technology, IP-to-MS. This immunoassay enables antigen identification and validation, as… Read More »“IP-to-MS: An Unbiased Workflow for Antigen Profiling” Published in JPR
Our R&D team has developed a new workflow that utilizes MT-Trypsin to facilitate rapid in-gel digestion of proteins followed by trypsin removal from peptide samples.… Read More »Impact Proteomics launches new in-gel digestion workflow utilizing MT-Trypsin
We’re happy to announce that Impact Proteomics has joined Science Exchange. Our IP-to-MS antigen discovery services as well as our multiomics and proteomics sample preparation… Read More »Impact Proteomics Joins Science Exchange
The innovation intelligence firm StartUs Insights has featured Impact Proteomics as one of the top 5 biotech startup companies advancing biochemistry solutions globally. StartUS Insights… Read More »Impact Proteomics Featured as one of the Top 5 Biotech Startups Advancing Biochemistry Solutions by StartUs Insights
Our Founder and CSO Jon Minden and CEO Jeff Whitmore met with Adam Washburn of Analytical Chemistry Startups to discuss Impact Proteomics’ technologies and company… Read More »Analytical Chemistry Startups Features Impact Proteomics and the “ProMTag Promise”
The global community for founders and startups, F6S, has recognized Impact Proteomics as #17 among the 100 top diagnostic companies and startups in the United… Read More »Impact Proteomics Listed Among 100 Top Diagnostics Companies and Startups in the United States by F6S
The Impact Proteomics team is thrilled to announce that Dr. Frederick Strathmann has joined our Board of Directors. Dr. Strathmann has been in laboratory medicine… Read More »Dr. Frederick Strathmann Joins Impact Proteomics’ Board of Directors
Impact Proteomics, LLC has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant for $1M to conduct research and development (R&D)… Read More »Impact Proteomics Awarded $1M Phase II SBIR grant from the National Science Foundation for development of ProMTag sample preparation technology